Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

REPROS THERAPEUTICS INC. (RPRX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09
   10-K10-K10-K10-K10-K10-K10-K10-K
Cash Flows from Operating Activities          
Net loss  -17.3-29.2-32.5-28.5-18.9-12.5-4.8-27.2
   
Adjustments to reconcile net loss to net cash used in operating activities:          
    Depreciation  0.00.00.00.00.00.10.10.1
    Noncash stock-based compensation  1.93.73.83.22.82.30.61.3
    Increase in prepaid expenses and other current assets  0.00.10.00.2-0.30.2-0.21.2
    Increase (decrease) in accounts payable and accrued expenses  -0.30.0-0.6-0.22.40.1-0.61.9
        Net cash used in operating activities  -15.6-25.3-29.3-25.3-14.1-9.8-5.0-22.1
   
Cash Flows from Investing Activities          
Capital expenditures     -0.10.00.00.0 
    Net cash used in investing activities     -0.10.0-0.3-0.4-0.5
   
Cash Flows from Financing Activities          
    Net cash provided by financing activities  2.90.10.177.033.811.76.45.0
    Net decrease in cash, cash equivalents and restricted cash  -12.7-25.2-29.251.619.61.61.1-17.6
   
Noncash transactions:          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy